LXRX Lexicon Pharmaceuticals, Inc.
$1.90▼ -4.29%
Healthcare
Other
Volume 623.0K
Avg Volume (10D) 2.58M
Key Metrics & Fundamentals
Market Cap
$843.19M
P/E Ratio
–
Div Yield
–%
52W Range
1.06 - 2.68
% vs 50 MA
-13.44%
% vs 200 MA
9.81%
RSI-14
31.3
MACD Histogram
-0.0300
Beta (1Y vs SPY)
1.46
Free Cash Flow
-$9.19M
Gross Rev
$692,000
Gross Profit
$653,000
EBITDA
-$24.72M
COGS
$39,000
Operating Exp
$27.19M
Operating Income
-$26.54M
EBIT
-$26.54M
Pretax Income
-$31.78M
Net Income
-$31.78M
EPS (Diluted)
-0.07
Price & Volume History
Loading chart…
Recent News
Lexicon Pharmaceuticals to Participate at Three Upcoming Investor Conferences
GlobeNewswire · Sep 1, 2026 8:05 PM
Lexicon Announces New Post Hoc SOLOIST-WHF Analysis Demonstrating Consistent Sotagliflozin Results Across Baseline Blood Pressure Levels in Patients with Recent Worsening Heart Failure
GlobeNewswire · Aug 31, 2026 12:30 PM
LXRX Stock Edges Higher On $10M Payout From Novo Nordisk — Retail Traders Highlight More Cash Milestones On The Horizon
Stocktwits · Aug 24, 2026 5:27 PM
Novo Nordisk (CPSE:NOVO B) Reaches LX9851 Obesity Drug Milestone
Simply Wall St. · Aug 24, 2026 5:09 PM
Lexicon Pharmaceuticals Gets $10 Million Novo Nordisk Milestone Payment for LX9851
MT Newswires · Aug 24, 2026 1:01 PM
Lexicon Pharmaceuticals Earns Third $10 Million Milestone Payment from Novo Nordisk Following Achievement of Key Phase 1 Development Milestone for LX9851
GlobeNewswire · Aug 24, 2026 12:30 PM
Hypertrophic Cardiomyopathy Market Set for Transformation Over the Next Decade with the Emergence of Targeted Cardiac Therapies Beyond Conventional Beta-blockers, Calcium Channel Blockers, and Antiarrhythmic Agents | DelveInsight
PR Newswire · Aug 17, 2026 2:32 PM
Lexicon (LXRX) Q2 2026 Earnings Call Transcript
Motley Fool · Aug 13, 2026 4:15 PM
Why Lexicon Pharmaceuticals (LXRX) Is Up 6.9% After Q2 Revenue Collapse And New Shelf Filings
Simply Wall St. · Aug 8, 2026 12:15 AM
Lexicon Pharmaceuticals Inc (LXRX) (Q2 2026) Earnings Call Highlights: Zynquista NDA ...
GuruFocus.com · Aug 6, 2026 11:18 PM
Financial Overview - Income Statement
Quarterly
Jun 2026
See LXRX's money flow as a full page
Social Sentiment
Avg +0.72 · 8 posts
TradeDiscussionI am not a Shill or Shilling anything. I wasn't even aware of what a shill was until being called one... That said... I'm enjoying the conversation and love the unique perspectives! $1.08 - $1.24.
r/investing · Sep 18, 2025
The author is reporting a positive price movement and framing it as a learning exercise. The sentiment is cautiously optimistic.
positive
+0.80
DiscussionDD1.08 to 1.22 that not a bad 1 day move. No Shill!
r/investing · Sep 18, 2025
The author states they are sharing their genuine interest and progress regarding LXRX, and welcomes discussion. This suggests a bullish sentiment.
positive
+0.70
DDNewsDiscussionTradeLXRX at $1.08 Is there a reason not to buy?
r/investing · Sep 17, 2025
The post highlights positive aspects like partnerships and pipeline developments, driving bullish sentiment.
positive
+0.70
DDNewsDiscussion$LXRX - Lexicon Pharmaceuticals - The Diabetes Pain Killer
r/investing · Aug 15, 2025
Strong positive sentiment due to FDA resubmission, Phase 3 trial progression, Novo Nordisk partnership, and strong fundamentals.
positive
+0.80
NewsEarningsDiscussionLxrx earnings report tomorrow big expectations
r/wallstreetbets · Apr 29, 2025
The author expresses optimism regarding LXRX's financials and potential, indicating a positive sentiment.
positive
+0.60
Page 1 of 2 (8 total)
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.